IGA NEPHROPATHY (IGAN)
Clinical trials for IGA NEPHROPATHY (IGAN) explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY (IGAN) trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Herbal granules aim to ease kidney disease in new trial
Disease control Not yet recruitingThis study tests whether Shenqi Yishen Granules, a traditional Chinese medicine, can reduce protein in the urine of adults with IgA nephropathy, a kidney disease. About 102 participants will receive either the granules or a placebo to check safety and effectiveness. The goal is t…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: NA • Sponsor: Keda Lu • Aim: Disease control
Last updated May 15, 2026 10:26 UTC
-
New cell shot aims to tame immune attacks on kidneys
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called GT719 in about 30 adults with kidney diseases caused by the immune system, such as IgA nephropathy and membranous nephropathy. The study has two phases: first, finding a safe dose, then testing that dose in more people. The m…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 16:02 UTC